AKT1 and gastric cancer: Moreover, ERIANIN can treat gastric precancerous lesions by modulating the HRAS/PI3K/AKT pathway, inhibiting MC activity, decreasing MDM2 expression, enhancing p53 activity, promoting early apoptosis of gastric cancer cells, and preventing cancer (24).